who should not use semaglutide Who Should Not Take Semaglutide Who Should Not Take Semaglutide

Zepbound addresses chronic weight management, while Mounjaro targets diabetes management

Take control of your health with our convenient, caring telehealth services, and book your consultation now

Both are formulations of the drug semaglutide, which mimics the action of the naturally occurring GLP-1 hormone on GLP-1 receptors in the gut and the brain, helping regulate appetite and making you feel fuller for longer

The primary endpoint was the percentage weight loss at six months (M6) compared to baseline

Semaglutide was initially FDA-approved under the brand name Ozempic for treating type 2 diabetes in adults in Grapevine/Southlake, TX